233 related articles for article (PubMed ID: 9176389)
1. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.
de Waal RM; van Altena MC; Erhard H; Weidle UH; Nooijen PT; Ruiter DJ
Am J Pathol; 1997 Jun; 150(6):1951-7. PubMed ID: 9176389
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
3. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and lymphangiogenesis of skin cancers.
Dadras SS; Detmar M
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
[TBL] [Abstract][Full Text] [Related]
6. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
7. Insights into the mechanisms of lymph node metastasis.
Nathanson SD
Cancer; 2003 Jul; 98(2):413-23. PubMed ID: 12872364
[TBL] [Abstract][Full Text] [Related]
8. Tumor lymphangiogenesis and melanoma metastasis.
Rinderknecht M; Detmar M
J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
[TBL] [Abstract][Full Text] [Related]
9. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis.
Erhard H; Rietveld FJ; van Altena MC; Bröcker EB; Ruiter DJ; de Waal RM
Melanoma Res; 1997 Aug; 7 Suppl 2():S19-26. PubMed ID: 9578413
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic vessel density is significantly increased in melanoma.
Giorgadze TA; Zhang PJ; Pasha T; Coogan PS; Acs G; Elder DE; Xu X
J Cutan Pathol; 2004 Nov; 31(10):672-7. PubMed ID: 15491327
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
[TBL] [Abstract][Full Text] [Related]
14. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
15. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
Niakosari F; Kahn HJ; Marks A; From L
Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
[TBL] [Abstract][Full Text] [Related]
16. Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma.
Ribatti D; Nico B; Floris C; Mangieri D; Piras F; Ennas MG; Vacca A; Sirigu P
Oncol Rep; 2005 Jul; 14(1):81-4. PubMed ID: 15944771
[TBL] [Abstract][Full Text] [Related]
17. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
18. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
Parsons-Wingerter P; McKay TL; Leontiev D; Vickerman MB; Condrich TK; Dicorleto PE
Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):233-47. PubMed ID: 16489601
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis in malignant tumours: Does it occur?
Clarijs R; Ruiter DJ; de Waal RM
J Pathol; 2001 Feb; 193(2):143-6. PubMed ID: 11180158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
